Clinical trial

Ologen (OculusGen)-Glaucoma Case Control Trial in India

NCT00448929

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-01-01

PhasePHASE3

Study timeline

Study start (actual)2007-01-01Date precision: month

Registry last updated2017-06-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

OculusGen Biodegradable Collagen Matrix ImplantDEVICE

Sponsors & collaborators

Pro Top & Mediking Company Limitedlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00448929 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.